About the event

We are hosting a generative AI event, designed specifically for key decision-makers in the pharma and life science industry. Our event will focus on the latest generative AI solutions, emerging challenges, and innovative solutions to help you and your business stay ahead of the curve.

During this event, you will hear from industry leaders and AI experts how they started their AI journey and how they are balancing technology and ethics. We share the latest industry developments, practical applications and give meaningful insights that allow you to take your business to the next level. Furthermore, our event provides a unique opportunity to network with other key decision-makers facing similar challenges.

How intelligent is your workforce experience? You will have the opportunity to discover how Microsoft`s CoPilot or custom Azure OpenAI based solutions can benefit your workforce and your business and gain an exclusive insight into why leaders need to start thinking about it now.

Our exclusive event has limited places to allow for engaged discussions. Register now and join us for an insightful and compelling experience that will help your business thrive. We are looking forward to welcoming you!

Participants

These events are aimed for employees in C-level positions, key decision-makers as well as other persons responsible for AI initiatives. Please note that places are limited.

Language

Please note that this event will be held in English

Agenda highlights

Keynote speech

Borke van Belle, Head of R&D Quality Process & Data Management at The Janssen Pharmaceutical Companies of Johnson & Johnson

Panel discussion with industry experts 

We will look at different aspects of the GenAI journey, with a particular focus on how to create real, sustainable outcomes at scale. Panelists will contribute their first hand experience either from a Azure OpenAI or a Copilot early adopter perspective. 

We will then take the discussion from the first lessons learnt to where each of the panellists plans to go in their very own respective GenAI journeys. 

• Florian Mohnert, Data Strategy Business Lead at Merck
• Merin Tahir, Digital Engagement lead EMEA at MSD

Prudently bold

PwC‘s perspective on how to respect compliance considerations, especially in light of the EU AI Act, while still embracing the opportunities which lie ahead.